Chong-Jen Yu

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Hyo Youl Kim, Kenjiro Nakamura, A. Schaefer, 2022, Open forum infectious diseases.

Journal Pre-proof Final Overall Survival, Other Efficacy and Safety Results from ASCEND-3: Phase II Study of Ceritinib in ALK i-Naïve Patients With ALK -Rearranged Non–Small-Cell Lung Cancer Phase II Study of in i-Naïve Patients With ALK -Rearranged Non–Small-Cell

A. Shaw, E. Felip, D. Spigel, 2019 .